GSK Sued Over Lyme Disease Vaccine
GlaxoSmithKline (GSK) has been hit with a dangerous drug lawsuit that alleges its Lyme disease vaccine LYMERix caused patients to develop arthritis.
The dangerous drug lawsuit claims that plaintiffs who were vaccinated with the medication in the 1990s were later diagnosed with post-Lyme disease treatment syndrome or treatment resistant Lyme arthritis, according to Law360 (subscription required).
“Defendants knew of the subject product’s defective and unreasonably dangerous nature…but continue to design, develop, manufacture, market, distribute, and sell it so as to maximize sales and profits at the expense of the health and safety of the public,” said the complaint.
The plaintiffs further allege that GSK continued to maintain claims regarding the safety and effectiveness of the drug even after cases of adverse effects began to appear, according to Law360. They are charging the company with fraud, negligence, breach of warranty, as well as other charges.
If you or a loved one has been harmed by a dangerous drug, contact Sokolove Law for a free legal consultation and to find out if a dangerous drug lawyer may be able to help you. For legal help, call (800) 581-6358.